Pinto, R.M.; Seabra, C.L.; De Jonge, M.; Martins, M.C.L.; Van Dijck, P.; Reis, S.; Nunes, C.
Antibiofilm Combinatory Strategy: Moxifloxacin-Loaded Nanosystems and Encapsulated N-Acetyl-L-Cysteine. Pharmaceutics 2022, 14, 2294.
https://doi.org/10.3390/pharmaceutics14112294
AMA Style
Pinto RM, Seabra CL, De Jonge M, Martins MCL, Van Dijck P, Reis S, Nunes C.
Antibiofilm Combinatory Strategy: Moxifloxacin-Loaded Nanosystems and Encapsulated N-Acetyl-L-Cysteine. Pharmaceutics. 2022; 14(11):2294.
https://doi.org/10.3390/pharmaceutics14112294
Chicago/Turabian Style
Pinto, Rita M., Catarina Leal Seabra, Martine De Jonge, M. Cristina L. Martins, Patrick Van Dijck, Salette Reis, and Cláudia Nunes.
2022. "Antibiofilm Combinatory Strategy: Moxifloxacin-Loaded Nanosystems and Encapsulated N-Acetyl-L-Cysteine" Pharmaceutics 14, no. 11: 2294.
https://doi.org/10.3390/pharmaceutics14112294
APA Style
Pinto, R. M., Seabra, C. L., De Jonge, M., Martins, M. C. L., Van Dijck, P., Reis, S., & Nunes, C.
(2022). Antibiofilm Combinatory Strategy: Moxifloxacin-Loaded Nanosystems and Encapsulated N-Acetyl-L-Cysteine. Pharmaceutics, 14(11), 2294.
https://doi.org/10.3390/pharmaceutics14112294